Researchers found that women who experience early menopause do not live as long and experience more years with type 2 diabetes mellitus.
Early Menopause Was Associated with Increased Risk of Cognitive Decline, Depression within 2 Years
The findings suggest that women who experience early menopause (age <40 vs >50 years) may constitute a sex-specific high-risk group for cognitive decline.
Elinzanetant Reduces Vasomotor Symptoms of Menopause Across BMI, Smoking Status
Pooled data from the OASIS clinical trial program showed consistent efficacy of elinzanetant across BMI and smoking history subgroups, highlighting its broad applicability.
Prepregnancy Obesity, Not Pregnancy Complications, Drives Midlife Cardiovascular Risk in Women, Suggest HAPO FUS Study Findings
Gestational diabetes and hypertensive disorders of pregnancy may be markers for rather than mediators of risk for future CVD, according to new research.
Mediterranean Diet Combined with Physical Activity Mitigate Bone Density Decline in Older, At-Risk Women, New Analysis Finds
Following a Mediterranean-style diet and a prescribed regimen of physical activity was significantly protective of BMD, particularly at the lumbar level, over 3 years.
FDA Approves Gepotidacin for Treatment of Uncomplicated UTIs: Daily Dose
Your daily dose of the clinical news you may have missed.
Expert Insights: Q&A with Mark Ebell, MD, on Gepotidacin and UTI Management
Family physician and researcher Mark Ebell, MD, discusses the clinical implications, efficacy, and role of gepotidacin in UTI management.